Patents Assigned to CMAX Technologies, Inc.
  • Patent number: 9561187
    Abstract: The present invention relates to modified release pharmaceutical composition comprising metoprolol succinate, one or more release modifying agent(s) and one or more pharmaceutically acceptable excipient(s). More specifically, the invention relates to modified release pharmaceutical compositions comprising metoprolol succinate and a process for preparation thereof.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: February 7, 2017
    Assignee: CMAX Technologies, Inc.
    Inventor: Laxminarayan Joshi